ES2180690T3 - Preparacion de composiciones que comprenden st1435 para aplicacion topica. - Google Patents

Preparacion de composiciones que comprenden st1435 para aplicacion topica.

Info

Publication number
ES2180690T3
ES2180690T3 ES96201585T ES96201585T ES2180690T3 ES 2180690 T3 ES2180690 T3 ES 2180690T3 ES 96201585 T ES96201585 T ES 96201585T ES 96201585 T ES96201585 T ES 96201585T ES 2180690 T3 ES2180690 T3 ES 2180690T3
Authority
ES
Spain
Prior art keywords
compositions
preparation
topical application
skin
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96201585T
Other languages
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ES2180690T3 publication Critical patent/ES2180690T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

EL ANALOGO DE LA PROGESTERONA 17 AL -ACETOXI-16-METILENO-19-NORPROGESTERONA (ST 1435) HA DEMOSTRADO TENER EFECTOS CONTRACEPTIVOS EFECTIVOS MEDIANTE SU APLICACION TOPICA SOBRE LA PIEL. EL ST 1435 PUEDE ADMINISTRARSE TOPICAMENTE EN UNA BASE SOLIDA O SEMISOLIDA COMO CREMA O GEL O EN UNA BASE LIQUIDA MEDIANTE UN DISPOSITIVO TRANSDERMICO TAL COMO DISCO, BANDA, PARCHE O BRAZALETE. EL ST 1435 TIENE UTILIDAD TAMBIEN PARA TRATAR TRASTORNOS DE PECHO BENIGNOS MEDIANTE APLICACION TOPICA.
ES96201585T 1990-06-01 1991-05-24 Preparacion de composiciones que comprenden st1435 para aplicacion topica. Expired - Lifetime ES2180690T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (1)

Publication Number Publication Date
ES2180690T3 true ES2180690T3 (es) 2003-02-16

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91912052T Expired - Lifetime ES2099747T3 (es) 1990-06-01 1991-05-24 Aplicacion topica terapeuticamente eficaz de la st1435.
ES96201585T Expired - Lifetime ES2180690T3 (es) 1990-06-01 1991-05-24 Preparacion de composiciones que comprenden st1435 para aplicacion topica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES91912052T Expired - Lifetime ES2099747T3 (es) 1990-06-01 1991-05-24 Aplicacion topica terapeuticamente eficaz de la st1435.

Country Status (10)

Country Link
US (1) US5651973A (es)
EP (3) EP1093816A3 (es)
JP (1) JP2625254B2 (es)
AT (2) ATE220912T1 (es)
CA (1) CA2083404C (es)
DE (2) DE69125855T2 (es)
DK (2) DK0754456T3 (es)
ES (2) ES2099747T3 (es)
GR (1) GR3023312T3 (es)
WO (1) WO1991018570A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0754456T3 (da) * 1990-06-01 2002-11-11 Population Council Inc Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003235716A1 (en) * 2002-01-17 2003-07-30 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
PL2450041T3 (pl) 2005-10-12 2019-02-28 Unimed Pharmaceuticals, Llc Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
US20110220817A1 (en) * 2008-08-12 2011-09-15 Moore John W Method of reducing the distortion of the electromagnetic field
BR112012014059B1 (pt) 2009-12-17 2020-03-10 The Population Council Inc. Gel transdérmico de progestina / estradiol
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
WO2016085912A1 (en) 2014-11-25 2016-06-02 Buckman Laboratories International, Inc. Felt conditioner and cleaner

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (es) * 1969-02-13 1970-08-17
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (es) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE58909570D1 (de) * 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
DK0754456T3 (da) * 1990-06-01 2002-11-11 Population Council Inc Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
EP0600873B1 (en) 1997-04-23
JP2625254B2 (ja) 1997-07-02
WO1991018570A1 (en) 1991-12-12
ATE151977T1 (de) 1997-05-15
DE69133077D1 (de) 2002-08-29
EP0754456B1 (en) 2002-07-24
DE69125855T2 (de) 1997-07-31
CA2083404C (en) 2001-02-20
EP1093816A2 (en) 2001-04-25
JPH07502253A (ja) 1995-03-09
DK0600873T3 (da) 1997-05-20
EP0754456A3 (en) 2000-02-02
GR3023312T3 (en) 1997-08-29
ES2099747T3 (es) 1997-06-01
CA2083404A1 (en) 1991-12-02
ATE220912T1 (de) 2002-08-15
EP0754456A2 (en) 1997-01-22
EP0600873A4 (en) 1993-09-02
DK0754456T3 (da) 2002-11-11
EP0600873A1 (en) 1994-06-15
DE69133077T2 (de) 2002-11-07
EP1093816A3 (en) 2003-10-22
DE69125855D1 (de) 1997-05-28
US5651973A (en) 1997-07-29

Similar Documents

Publication Publication Date Title
ES2180690T3 (es) Preparacion de composiciones que comprenden st1435 para aplicacion topica.
ATE229802T1 (de) Zusammenstellung aus gemischten cyanoacrylatestern
EA200201000A1 (ru) Гормон-заместительная терапия
ES2052682T3 (es) Una composicion farmaceutica potenciadora de la penetracion para aplicacion topica.
PT748190E (pt) Metodos e formulacoes para uso no tratamento de disturbios ginecologicos benignos
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2063073T3 (es) Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios.
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
WO2006053172A3 (en) The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
BR0010113A (pt) Preparações para uso externo na pele
NZ333324A (en) Prophylactic treatment of skin sensitization and irritation
WO2003063791A3 (en) Non-steroidal analogs of 2-methoxyestradiol
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE128622T1 (de) Behandlungsmittel.
ES2173858T3 (es) Analogos de huperzina a.
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
BR9912816A (pt) Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
BR0009194A (pt) Composição do resorcinol
IE780497L (en) Broparestrol based therapeutic compositions
GT199900171A (es) Concentrado oral de sertralina.